Zynex inc.
Nov 10, 2023 · As of November 09, 2023, Zynex Inc. had a $306.8 million market capitalization, putting it in the 51st percentile of companies in the Advanced Medical Equipment & Technology industry. Currently, Zynex Inc.’s price-earnings ratio is 20.7. Zynex Inc.’s trailing 12-month revenue is $185.8 million with a 8.6% profit margin.
Zynex, Inc. develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. The Company's devices are intended for pain management and provide rehabilitation and through the utilization of …Zynex, Inc. develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. The Company's devices are intended for pain management and provide rehabilitation and through the utilization of …Jul 12, 2023 · ENGLEWOOD, Colo., July 12, 2023 / PRNewswire / -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for second quarter 2023 and reiterated full-year guidance. На 02.12.2023 стоимость одной акции компании Zynex Inc составляет 9.04 долларов. Сделка по покупке актива производится на Санкт-Петербургской бирже. Доступна ...
Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than ...
Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...
Zynex Inc shares valued at $169,800 were sold by MOORHEAD DANIEL J on Aug 04. At $8.49 per share, MOORHEAD DANIEL J sold 20,000 shares. The insider’s holdings dropped to 24,179 shares worth approximately $0.21 million following the completion of this transaction. The electric vehicle boom is accelerating – and fast.Zynex, Inc. develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. The Company's devices are intended for pain management and provide rehabilitation and through the utilization of …Orders increased 48%; highest number of orders in Company history for the 3 rd consecutive quarter. Revenue increased 21% year over year to $48.8 million. Net income of $7.5 million; Diluted EPS …WebZynex, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $0.09. Operator: Good day ladies and gentlemen, and welcome to the Zynex Third Quarter 2023 Earnings Conference Call.
What is Zynex NexWave? Zynex Medical Inc. is part of three subsidiaries of the company founded in 1996 by Thomas Sandgaard. It is a medical manufacturer of electrotherapy products for pain relief and management. Zynex Nexwave is one of their products from the line of electrotherapy products. It is a device that incorporates IFC, …
ZYNEX, INC., f/k/a ZYNEX MEDICAL HOLDINGS, INC., THOMAS SANDGAARD and FRITZ G. ALLISON, Defendants. Civil Action No. 09-cv-00816-MSK-MJW ROBERT HANRATTY ...
Zynex Recognized in Top 100 Healthcare Technologies Companies for Second Year in a Row Read More. OCT 12, 2023 Zynex, Inc Sets Third Quarter 2023 Earnings Call Read More. View all. Safe Harbor for Forward-Looking Statement . Forward-looking statements are neither historical facts nor assurances of future performance. …Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...Zynex, Inc. (NASDAQ:ZYXI) posted its quarterly earnings data on Thursday, October, 26th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. The firm had revenue of $49.92 million for the quarter, compared to analyst estimates of $49.50 million.Zynex, Inc. (NASDAQ:NASDAQ:ZYXI) Q3 2023 Earnings Conference Call October 26, 2023 4:15 PM ETCompany ParticipantsQuinn Callanan - Investor RelationsThomas...0.49%. $58.97M. ZYXI | Complete Zynex Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Web
In August 2023, the company introduced three new pain management therapy products, including the Zynex Pro Thoracic Lumbar Sacral Orthosis (“TLSO”), Zynex Pro ...16.99%. Created with Highstock 2.1.8. Zynex Inc. Annual stock financials by MarketWatch. View the latest ZYXI financial statements, income statements and financial ratios.Find real-time ZYXI - Zynex Inc stock quotes, company profile, news and forecasts from CNN Business.Fax your prescription to 866-791-2026 . If you are with a doctor’s office or physical therapy clinic, please include a cover sheet with the clinic/practice name with your fax. 2. Zynex will take care of the rest! We will call to review insurance information, ship the device to your doorstep, and provide instructions to use it.Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...
Zynex, Inc. Common Stock (ZYXI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...Zynex, Inc. announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical …WebZynex, Inc. announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical …WebTrack Zynex Inc (ZYXI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsZynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood ...May 3, 2023 · ENGLEWOOD, Colo., May 3, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced its intent to offer, subject to market conditions and other factors, $50 million aggregate principal amount of its convertible senior notes due 2026 (the "Notes") in a private offering (the "Notes Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule ... Zynex, Inc., a leading medical technology company specializing in the production and sale of innovative non-invasive medical devices for pain relief, rehabilitation, and patient monitoring, has made an exciting announcement. On November 1, 2023, the company’s board of directors gave their approval for a stock repurchase program, …Zynex 40mg Capsules (Hard Gelatin) manufactured by Oman Pharmaceutical Products. Its generic name is Esomeprazole Magnesium Trihydrate. Zynex is availble in United Arab Emirates. Farmaco UAE drug index information on Zynex Capsules (Hard Gelatin) is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute …
Zynex, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $0.09. Operator: Good day ladies and gentlemen, and welcome to the Zynex Third Quarter 2023 Earnings Conference Call.
Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced that Thomas Sandgaard, its Chief Executive Officer (the "Selling Stockholder"), has determined not to pursue the public offering of 2,000,000 ...
Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...Aug 3, 2023. Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET. Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management ...Nov 24, 2023 · Zynex, Inc. (NASDAQ:ZYXI) posted its quarterly earnings data on Thursday, October, 26th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. The firm had revenue of $49.92 million for the quarter, compared to analyst estimates of $49.50 million. Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...Zynex's presentation will be held in person and webcast live on September 26 th at 1:35 PM ET at the InterContinental Barclay Hotel in New York, NY.You can listen to the webcast at Zynex Investor Presentation Webcast. Thomas Sandgaard, Founder and CEO, and Dan Moorhead, CFO, will be available for one-on-one meetings on September …Zynex Inc., which belongs to the Zacks Medical - Products industry, posted revenues of $49.92 million for the quarter ended September 2023, surpassing the Zacks Consensus Estimate by 0.84%. This ...Nov 15, 2023 · Zynex. 15 Nov, 2023, 09:15 ET. ENGLEWOOD, Colo., Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non ... May 4, 2023 · Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced that Thomas Sandgaard, its Chief Executive Officer (the "Selling Stockholder"), has determined not to pursue the public offering of 2,000,000 ...
Feb 23, 2023 · Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ... Zynex Inc is a medical technology company based in Englewood, Colorado. Founded in 1996, it is the leading provider of electrotherapy devices for pain management, stroke rehabilitation, and neurological assessment. Its products include electrotherapy, exercise systems, and stroke rehabilitation equipment, and its services include home health ...Oct 26, 2023 · Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ... 14 Okt 2011 ... Zynex Inc. has built its reputation with hospitals and patients by focusing on developing medical devices ignored by larger medical ...Instagram:https://instagram. reviews of delta dentalhow to buy hnhpf stockoffshore forex brokerhsbc trading platform Nov 1, 2023 · Zynex, Inc. had approximately 41.9 million shares issued and 33.9 million shares outstanding as of October 30, 2023. About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and ... day trading platforms with no minimum depositinternet of everything stocks Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...On March 6, 2023, Zynex announced that the Company was postponing release of its fourth quarter and full year financial results and conference call initially scheduled for March 6, 2023 to allow ... tesla x investment app Apr 29, 2023 · Zynex, Inc. (NASDAQ:NASDAQ:ZYXI) Q1 2023 Earnings Conference Call April 27, 2023 4:15 PM ETCompany ParticipantsLouisa Smith - Investor RelationsThomas... Apr 27, 2023 · ENGLEWOOD, Colo., April 27, 2023 / PRNewswire / -- Zynex, Inc. ( Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the first quarter ended March 31, 2023. Zynex, Inc. 9.32-0.05-0.51%: TRENDING. 1. Why it took 17 days for rescuers in India to get to 41 workers trapped in a mountain tunnel. 2. Amazon's AWS appeals to corporate customers with new ...